20 months after the 40,000 trial subjects were given the Oxford/AZ vaccine, no loss of protection from serious illness has been observed in under 70s who had 2 doses of AstraZeneca almost 2 years ago - Sarah Gilbert.
AZ designed as a 2 dose vaccine, not 3, not boost-dependent.